sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension
sST2 and IL-6 are independent prognostic biomarkers in medically treated CTEPH. Their combined use enhances risk stratification and adds incremental value to existing risk models.
Authors
- B Qiu
- Yuping Zhou (ORCID: https://orcid.org/0000-0003-0693-4747)
- Xin Jiang (ORCID: https://orcid.org/0000-0002-4613-7438)
- M. D. Hui Liu
- S Li
- Si-Jin Zhang
- Xi-Qi Xu
- Jinghui Li (ORCID: https://orcid.org/0000-0002-5095-3921)
- Yin-Jian Yang (ORCID: https://orcid.org/0000-0003-3048-1215)
- Tian-Yu Lian
- Xi-Jie Zhu
- Hui-Hui Xu
- Chun-Yan Cheng
- Jing-Si Ma
- Yi-Min Mao
- Kai Sun
- Wen-Hui Wu
- Ying-Ying Cheng
- Ze-Jian Zhang
- Zhi-Cheng Jing
- Chao Liu
Institutions
- Tongji University (CN)
- Henan University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Zero to Three (US)
- Shanghai Pulmonary Hospital (CN)
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Guangdong Academy of Medical Sciences (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1183/13993003.02367-2025
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00